Skip to main content
Log in

Pharmacological Management of Borderline Personality Disorder in a Pregnant Woman with a Previous History of Alcohol Addiction: A Case Report

  • Case Report
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Abstract

The clinical utilization of psychotropic medications in pregnant women represents a significant challenge. Indeed, the risks of untreated severe mental disorders, particularly when complicated by substance-related and addictive disorders, must be carefully balanced against the potential teratogenic risks of pharmacological treatment. In this case, an alcohol addict, diagnosed with borderline personality disorder was treated successfully with several classes of psychotropic agents during the first trimester. In September 2014, while taking trazodone, lorazepam, quetiapine, mirtazapine, and flurazepam, this patient became aware that she was pregnant. After a perinatal psychiatrist consultation requested four months later, trazodone and flurazepam were progressively suspended and daily doses of lorazepam and quetiapine were lowered gradually. Mirtazapine dose remained unchanged. Apart from a mild gastro-esophageal reflux disease, birth outcome was normal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Gentile S. Anxiety and sleep disorders, psychopharmacology and pregnancy. In: Psychopharmacology and pregnancy. Galbally, Snellen, and Lewis Edits. Berlin: Springer-Verlab; 2014. p. 87–102.

  2. Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull. 2010;36:518–44.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Gentile S. Pregnancy exposure to second-generation antipsychotics and the risk of gestational diabetes. Exp Opin Drug Saf. 2014;13:1583–90.

    Article  CAS  Google Scholar 

  4. Butcher JN, Dahlstrom WG, Graham JR, et al. The Minnesota Multiphasic Personality Inventory-2 (MMPI-2) manual for administration and scoring. Minneapolis: University of Minneapolis Press; 1989.

    Google Scholar 

  5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: American Psychiatric Association; 2013.

    Book  Google Scholar 

  6. Gentile S. Quetiapine-fluvoxamine combination during pregnancy and while breastfeeding. Arch Womens Ment Health. 2006;9:158–9.

    Article  CAS  PubMed  Google Scholar 

  7. Sadowski A, Todorow M, Yazdani Brojeni P, et al. Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. BMJ Open. 2013;3(7):e003062. doi:10.1136/bmjopen-2013-003062.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Bridler R, Häberle A, Müller ST, et al. Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: a comparison with other psychiatric disorders. Eur Neuropsychopharmacol. 2015;25(6):763–72.

    Article  CAS  PubMed  Google Scholar 

  9. Schatzberg AF. New indications for antidepressants. J Clin Psychiatry. 2000;61(Suppl 11):9–17.

    CAS  PubMed  Google Scholar 

  10. Gentile S. On categorizing gestational birth, and neonatal complications following late in utero exposure to antidepressants. The prenatal antidepressant exposure syndrome. CNS Spectr. 2010;15(3):167–85.

    PubMed  Google Scholar 

  11. Smit M, Wennink HJMB, Heres MMHB, et al. Mirtazapine in pregnancy and lactation. Data from a case series. J Clin Psychopharmacol. 2015;35(2):163–7.

    Article  CAS  PubMed  Google Scholar 

  12. Stoffers JM, Völlm BA, Rücker G, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2012;8:CD005652.pub2. doi:10.1002/14651858.

  13. Laaksonen E, Vuoristo-Myllys S, Koski-Jannes A, et al. Combining medical treatment and CBT in treating alcohol-dependent patients: effects on life quality and general well-being. Alcohol Alcohol. 2013;48(6):687–93.

    Article  CAS  PubMed  Google Scholar 

  14. Stoner SC, Sommi RW Jr, Marken PA, et al. Clozapine use in two full-term pregnancies. J Clin Psychiatry. 1997;58:364–5.

    Article  CAS  PubMed  Google Scholar 

  15. Marienfeld C, Rosenheck RA. Psychiatric services and prescription fills among veterans with seriously mental illness in methadone maintenance treatment. J Dual Diagn. 2015;11(2):128–35.

    Article  PubMed  Google Scholar 

  16. Grigoriadis S, Vonderporten EH, Mamisashvili L, et al. The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry. 2013;74:e309–20.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Salvatore Gentile.

Ethics declarations

Funding

This case-report was supported by neither sources of funding nor editorial assistance.

Conflicts of interest

Dr. Gentile has no conflicts of interest to disclose.

Ethical approval

All procedures in this study were in accordance with the 1964 Helsinki Declaration (and its amendments). No approval by ethical committee or institutional review board was needed.

Informed consent

Written evidence of patient’s consent to publish this report is available on her medical records shielded at Mental Health Operative Unit n. 63—Piazza Galdi—84013—Cava de’ Tirreni (Salerno)—Italy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gentile, S. Pharmacological Management of Borderline Personality Disorder in a Pregnant Woman with a Previous History of Alcohol Addiction: A Case Report. Clin Drug Investig 35, 761–763 (2015). https://doi.org/10.1007/s40261-015-0337-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40261-015-0337-z

Keywords

Navigation